Triamcinolone Acetonide
- Product NDC
- 25021-054
- 11-digit product format
- 250210054
- Labeler code
- 25021
- Product ID
- 25021-054_01da5682-a8f6-483b-afc4-b4f9ca6a7b12
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamcinolone Acetonide
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRA-ARTICULAR; INTRAMUSCULAR
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA218601
- Marketing category
- ANDA
- Marketing start
- 2026-03-01
- Substance
- TRIAMCINOLONE ACETONIDE
- Active strength
- 40 mg/mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data
- Finished product
- Yes
- Brand name base
- Triamcinolone Acetonide
- Listing expiration
- 2027-12-31
Active Ingredients
| Ingredient | Strength |
|---|
| TRIAMCINOLONE ACETONIDE | 40 mg/mL |
Harmonized Identifiers
| Field | Values |
|---|
| Unii | F446C597KA |
| Rxcui | 1792144 |
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| F446C597KA | TRIAMCINOLONE ACETONIDE | 76-25-5 | TRIAMCINOLONE ACETONIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 25021-054-01 | 25021005401 | 25 VIAL in 1 CARTON (25021-054-01) / 1 mL in 1 VIAL | 25 vial | 2026-03-01 | No | No | Current |